The DOI matches its Crossref record.
(Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Peptide Transporters: Structure, Function, Regulation and Application for Drug Delivery
Abstract
Proton-coupled peptide transporters, localized at brush-border membranes of intestinal and renal epithelial cells, play important roles in protein absorption and the conservation of peptide-bound amino nitrogen. These transporters also have significant pharmacological and pharmacokinetic relevance to the transport of various peptide-like drugs such as beta-lactam antibiotics. The identification and molecular characterization of H(+)/peptide cotransporters (PEPT1 and PEPT2) have facilitated the clarification of many aspects of these transporters such as the structure/function relationship and regulation. Recent findings that intestinal PEPT1 can transport l-valine ester prodrugs such as valacyclovir provided a major step forward toward the development of novel drug delivery systems. It has been demonstrated that peptide transporters, which have a similar substrate specificity to PEPT1 and PEPT2, but possess other distinct functional properties, are localized at basolateral membranes of intestinal and renal epithelial cells. This review highlights the recent advances in our knowledge of the cellular and molecular nature of PEPT1, PEPT2 and the basolateral peptide transporters.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A significant disadvantage of DFO is that it does not seem to cross the intestine intact (despite the rather catholic substrate specificity of intestinal peptide transporters [1682-1685]) and must therefore be given intravenously or subcutaneously.”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1684]
Citations
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Transporters as a determinant of drug clearance and tissue distribution
Shitara, Y., Horie, T., & Sugiyama, Y. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.12.003 · Cited by 496
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Dobson, P. D., & Kell, D. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2438 · Cited by 475
Brown, T. P., & Ganapathy, V. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107451 · Cited by 481
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
Zhou, S.-F. (2008) · Xenobiotica · doi:10.1080/00498250701867889 · Cited by 599
“Additionally, members of the OATP, OCT (OCT1-3) and OAT (OAT1, 3, 4) transporter families have been identified in the basolateral membrane of proximal tubule cells (Terada and Inui 2004; Van de Water et al. 2005; Launay-Vacher et al. 2006; Sekine et al. 2006).”
BackgroundExpression and function of efflux drug transporters in the intestine
Takano, M., Yumoto, R., & Murakami, T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.005 · Cited by 356
Smith, D. E., Clémençon, B., & Hediger, M. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.11.003 · Cited by 326
“Functional studies have shown that basolateral transport systems for peptides/mimetics in intestine, kidney and choroid plexus are distinct from that of PepT1 and PepT2 (Shu et al., 2001, 2002; Smith et al., 2004; Terada and Inui, 2004).”
Peptide transporters and their roles in physiological processes and drug disposition
Rubio-Aliaga, I., & Daniel, H. (2008) · Xenobiotica · doi:10.1080/00498250701875254 · Cited by 238
“Foreign compounds that utilize peptide transporters for transport include amino -lactam antibiotics of the cephalosporin and penicillin classes, as well as certain angiotensinconverting enzyme inhibitors, selected renin inhibitors (S 86 2033 and S 86 3390), antitumour agents such as bestatin, dopamine receptor antagon…”
BackgroundPharmaceutical and pharmacological importance of peptide transporters
Brandsch, M., Knütter, I., & Bosse-Doenecke, E. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.5.0002 · Cited by 221
“…published and there are many reviews and books available on the topic of drug/prodrug transport via the peptide transporters (for review see Leibach & Ganapathy 1996; Brodin etal 2002; Daniel & Rubio-Aliaga 2003; Nielsen & Brodin 2003; Brandsch et al 2004; Terada & Inui 2004; Biegel et al 2006b).”
BackgroundMillan, M. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2199-1 · Cited by 221
“Astrocytes do not only cleave NAAG: they also take it up via a proton-coupled di/tripeptide transporter termed “PEPT2” (Fujita et al. 2004; Terada and Inui 2004).”
BackgroundFrom Bacteria to Man: Archaic Proton-Dependent Peptide Transporters at Work
Daniel, H., Spanier, B., Kottra, G., & Weitz, D. (2006) · Physiology · doi:10.1152/physiol.00054.2005 · Cited by 196
“In addition to the large number of di- and tripeptides, peptidomimetics such as amino beta-lactam antibiotics, selected angiotensin-converting enzyme inhibitors, and some antiviral nucleoside prodrugs as well as omega-amino fatty acids do serve as substrates (11, 14, 68).”
BackgroundHulmi, J. J., Lockwood, C. M., & Stout, J. R. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-51 · Cited by 238
“For example, it is possible that via the PEPT-1 cotransporters' high capacity, low specificity rate of transport, and an apparent increased transport affinity for L-valine bound peptides, that the bound form of an EAA may be more efficiently utilized than when delivered in its free-form [119].”
Chu, X.-Y., Bleasby, K., Yabut, J., Cai, X., Chan, G. H., Hafey, M. J., Xu, S., Bergman, A. J., Braun, M. P., Dean, D. C., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116517 · Cited by 179
“Since sitagliptin has a peptide-like structure, one potential candidate is the human oligopeptide transporter hPEPT1 (Terada and Inui, 2004).”
BackgroundInfluentialHellwig, M., Geissler, S., Matthes, R., Peto, A., Silow, C., Brandsch, M., & Henle, T. (2011) · ChemBioChem · doi:10.1002/cbic.201000759 · Cited by 167
Research advances and application of pulsed electric field on proteins and peptides in food
Zhang, S., Sun, L., Ju, H., Bao, Z., Zeng, X., & Lin, S. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109914 · Cited by 155
De Leo, F., Panarese, S., Gallerani, R., & Ceci, L. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789271834 · Cited by 149
Prodrug Approaches for Enhancing the Bioavailability of Drugs with Low Solubility
Müller, C. E. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900114 · Cited by 146
How functional foods play critical roles in human health
Pang, G., Xie, J., Chen, Q., & Zhi-he, H. (2012) · Food Science and Human Wellness · doi:10.1016/j.fshw.2012.10.001 · Cited by 150
Niida, A., Tomita, K., Mizumoto, M., Tanigaki, H., Terada, T., Oishi, S., Otaka, A., Inui, K., & Fujii, N. (2006) · Organic Letters · doi:10.1021/ol052781k · Cited by 117
Self-citationReimer, R. A. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06557 · Cited by 115
“While our cells did not express the HC-coupled peptide transporter 1 (PEPT1), which mediates transport of small peptides from the lumen into cells (Terada & Inui 2004), we did confirm the presence of several of the same amino acid transporters (ATA-2, ASCT-2 and yCLAT2) reported by Reimann et al.…”
BackgroundPan, X., Terada, T., Okuda, M., & Inui, K. (2004) · Journal of Nutrition · doi:10.1093/jn/134.9.2211 · Cited by 109
Self-citationTransport of drugs by proton-coupled peptide transporters: pearls and pitfalls
Brandsch, M. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903042292 · Cited by 123
“Increasing the distance between the peptide bond and the C-terminal carboxy group is much better tolerated than doing the same at the amino terminus [1-4,12,21].”
BackgroundIntestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel
Miner-Williams, W. M., & Moughan, P. J. (2016) · Nutrition Research Reviews · doi:10.1017/s0954422416000019 · Cited by 108
“It is thought that the transport of peptides across the basolateral membrane is mediated through other transporters such as those suggested by Terada et al.((322,323)), Shepherd et al.”
Salinity regulates claudin mRNA and protein expression in the teleost gill
Tipsmark, C. K., Baltzegar, D. A., Özden, Ö., Grubb, B. J., & Borski, R. J. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00112.2007 · Cited by 106
Structural insights into substrate recognition in proton‐dependent oligopeptide transporters
Guettou, F., Quistgaard, E. M., Tresaugues, L., Moberg, P., Jegerschöld, C., Zhu, L., Jong, A. J. O., Nordlund, P., & Löw, C. (2013) · EMBO Reports · doi:10.1038/embor.2013.107 · Cited by 98
“Furthermore, owing to their promiscuous substrate portfolio, many additional pharmacologically active compounds can potentially be converted into substrates for PEPT1 and PEPT2 and thus utilize these proteins as drug delivery systems [8].”
The renal type H+/peptide symporter PEPT2: structure-affinity relationships
Biegel, A., Knütter, I., Hartrodt, B., Gebauer, S., Theis, S., Luckner, P., Kottra, G., Rastetter, M., Zebisch, K., Thondorf, I., et al. (2006) · Amino Acids · doi:10.1007/s00726-006-0331-0 · Cited by 112
“Reviews on the trans- port mechanism are presented in the following articles: Daniel (1996), Leibach and Ganapathy (1996), Meredith and Boyd (2000), Herrera-Ruiz and Knipp (2003), Daniel and Kottra (2004), and Terada and Inui (2004).”
BackgroundInfluentialTissue distribution and thyroid hormone regulation of Pept1 and Pept2 mRNA in rodents
Lü, H., & Klaassen, C. D. (2005) · Peptides · doi:10.1016/j.peptides.2005.08.012 · Cited by 95
Transport of Angiotensin-Converting Enzyme Inhibitors by H+/Peptide Transporters Revisited
Knütter, I., Wollesky, C., Kottra, G., Hahn, M. G., Fischer, W., Zebisch, K., Neubert, R. H. H., Daniel, H., & Brandsch, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143339 · Cited by 100
“In the kidney tubule, di- and tripeptides are reabsorbed by PEPT1 and by the high-affinity H /peptide cotransporter PEPT2 (for review, see Nielsen and Brodin, 2003; Brandsch et al., 2004; Daniel and Kottra, 2004; Terada and Inui, 2004; Biegel et al., 2006).”
BackgroundTranscriptomic approach to the study of osmoregulation in the European eelAnguilla anguilla
Kalujnaia, S., McWilliam, I., Zaguinaiko, V. A., Feilen, A. L., Nicholson, J., Hazon, N., Cutler, C. P., & Cramb, G. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00059.2007 · Cited by 95
“The PepT-1 gene product has been immunolocalized to the villous brush border of enterocytes from all segments of the rat small intestine (100) and is the proton-coupled transporter for a variety of small peptides and drugs in both the intestine and the kidney (40, 108).”
BackgroundEffect of Fruit Juices on the Oral Bioavailability of Fexofenadine in Rats
Kamath, A. V., Yao, M., Zhang, Y., & Chong, S. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20231 · Cited by 87
Ding, L., Wang, L., Zhang, T., Yu, Z., & Liu, J. (2018) · Food Research International · doi:10.1016/j.foodres.2017.12.080 · Cited by 88
Selectivity mechanism of a bacterial homolog of the human drug-peptide transporters PepT1 and PepT2
Guettou, F., Quistgaard, E. M., Raba, M., Moberg, P., Löw, C., & Nordlund, P. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2860 · Cited by 79
Terada, T., Shimada, Y., Pan, X., Kishimoto, K., Sakurai, T., Doi, R., Onodera, H., Katsura, T., Imamura, M., & Inui, K. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.027 · Cited by 82
Self-citationGene expression and regulation of drug transporters in the intestine and kidney
Terada, T., & Inui, K. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.010 · Cited by 77
Self-citationIto, K., Hikida, A., Kawai, S., Lan, V. T. T., Motoyama, T., Kitagawa, S., Yoshikawa, Y., Kato, R., & Kawarasaki, Y. (2013) · Nature Communications · doi:10.1038/ncomms3502 · Cited by 77
Weitz, D., Harder, D., Casagrande, F., Fotiadis, D., Obrdlik, P., Kelety, B., & Daniel, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604866200 · Cited by 76
Molecular Mechanism of Ochratoxin A Transport in the Kidney
Anzai, N., Jutabha, P., & Endou, H. (2010) · Toxins · doi:10.3390/toxins2061381 · Cited by 82
Shimakura, J., Terada, T., Shimada, Y., Katsura, T., & Inui, K. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.001 · Cited by 73
Self-citationExpression and regulation of the neutral amino acid transporter B0AT1 in rat small intestine
Jando, J., Camargo, S. M. R., Herzog, B., & Verrey, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184845 · Cited by 78
Expression Profile and Functional Activity of Peptide Transporters in Prostate Cancer Cells
Tai, W., Chen, Z., & Cheng, K. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300364k · Cited by 69
Biomedical applications of dipeptides and tripeptides
Santos, S., Torcato, I. M., & Castanho, M. A. R. B. (2012) · Biopolymers · doi:10.1002/bip.22067 · Cited by 78
Molecular Modeling of PepT1 — Towards a Structure
Meredith, D., & Price, R. A. (2006) · The Journal of Membrane Biology · doi:10.1007/s00232-006-0876-6 · Cited by 65
“…for pharmacologists, as they transport various peptide-like drugs (‘peptidomimetics’) such as the b-lactam antibiotics, angiotensin-converting enzyme (ACE) inhibitors for hypertension, anti-virals such as valacyclovir, and anti-cancer agents such as bestatin (see Terada & Inui, 2004 for a review).”
BackgroundThe oligopeptide transporter hPepT1: gateway to the innate immune response
Charrier, L., & Merlin, D. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700423 · Cited by 71
Regulatory mechanism governing the diurnal rhythm of intestinal H+/peptide cotransporter 1 (PEPT1)
Saito, H., Terada, T., Shimakura, J., Katsura, T., & Inui, K. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90317.2008 · Cited by 69
Self-citationRønnestad, I., Gavaia, P. J., Viegas, C., Verri, T., Romano, A., Nilsen, T. O., Jordal, A. O., Kamisaka, Y., & Cancela, M. L. (2007) · Journal of Experimental Biology · doi:10.1242/jeb.007898 · Cited by 62
Tsuda, M., Terada, T., Irie, M., Katsura, T., Niida, A., Tomita, K., Fujii, N., & Inui, K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102830 · Cited by 61
“H -coupled peptide transporter 1 (PEPT1) expressed in the brush-border membranes of intestinal epithelial cells transports dipeptides and tripeptides from the lumen into cells using an inward H -electrochemical gradient (Inui and Terada, 1999; Daniel, 2004; Terada and Inui, 2004).”
BackgroundSelf-citationStructural basis for prodrug recognition by the SLC15 family of proton-coupled peptide transporters
Minhas, G. S., & Newstead, S. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1813715116 · Cited by 62
Future Direction of Renal Positron Emission Tomography
Szabó, Z. R., Xia, J., Mathews, W. B., & Brown, P. R. (2005) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2005.08.003 · Cited by 57
Shimakura, J., Terada, T., Saito, H., Katsura, T., & Inui, K. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00171.2006 · Cited by 63
“Because of its broad substrate specificity, PEPT1 can accept several peptidelike drugs such as oral -lactam antibiotics (39) and plays important roles not only as a nutrient transporter but also as a drug transporter.”
BackgroundSelf-citationIkemura, K., Iwamoto, T., & Okuda, M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.002 · Cited by 59
Protein Digestion and Absorption
Ganapathy, V. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00059-2 · Cited by 64
Shimakura, J., Terada, T., Katsura, T., & Inui, K. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00025.2005 · Cited by 50
Self-citationde Castro, W. V., Mertens‐Talcott, S. U., Derendorf, H., & Butterweck, V. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0728451 · Cited by 53
Terada, T., & Hira, D. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1061-4 · Cited by 53
Self-citationGourdon, B., Chemin, C., Moreau, A., Arnauld, T., Baumy, P., Cisternino, S., Péan, J., & Declèves, X. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.024 · Cited by 50
Zhu, L., Lu, L., Wang, S., Wu, J., Shi, J., Yan, T., Xie, C., Li, Q., Hu, M., & Liu, Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802447-8.00011-x · Cited by 55
Ganesh, A. N., Heusser, C., Garad, S., & Sánchez-Félix, M. V. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100079 · Cited by 50
Uptake, Transport and Regulation of JBP485 by PEPT1 in vitro and in vivo
Liu, Z., Wang, C., Liu, Q., Meng, Q., Cang, J., Mei, L., Kaku, T., & Liu, K. (2011) · Peptides · doi:10.1016/j.peptides.2011.01.019 · Cited by 50
Characterization of oligopeptide transporter (PepT1) in grass carp (Ctenopharyngodon idella)
Liu, Z., Zhou, Y., Feng, J., Lu, S., Zhao, Q., & Zhang, J. (2012) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2012.11.008 · Cited by 43
The mammalian proton-coupled peptide cotransporter PepT1: sitting on the transporter–channel fence?
Meredith, D. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.0139 · Cited by 43
Efflux properties of basolateral peptide transporter in human intestinal cell line Caco-2
Irie, M., Terada, T., Okuda, M., & Inui, K. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-004-1326-x · Cited by 43
Self-citationProtein Digestion and Absorption
Bhutia, Y. D., & Ganapathy, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00047-5 · Cited by 48
Transporter-mediated uptake into cellular compartments
Oswald, S., Grube, M., Siegmund, W., & Kroemer, H. K. (2007) · Xenobiotica · doi:10.1080/00498250701570251 · Cited by 49
“This protein is expressed at the apical membrane of enterocytes in the proximal small intestine and mediates the uptake of peptides and a substantial number of drugs including penicillins, cephalosporins, ACE-inhibitors as well as antiviral and anticancer drugs (Kunta and Sinko 2004; Terada and Inui 2004).”
BackgroundAhmed, M., Liang, H., Kasiya, H. C., Ji, K., Ge, X., Ren, M., Liu, B., Zhu, X., & Sun, A. (2018) · Aquaculture Nutrition · doi:10.1111/anu.12844 · Cited by 68
Noshiro, R., Anzai, N., Sakata, T., Miyazaki, H., Terada, T., Shin, H. J., He, X., Miura, D., Inui, K., Kanai, Y., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5001522 · Cited by 40
Self-citationRegulation of human peptide transporter 1 (PEPT1) in gastric cancer cells by anticancer drugs
Inoue, M., Terada, T., Okuda, M., & Inui, K. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.12.023 · Cited by 41
Self-citationWang, L., Ding, L., Du, Z., & Liu, J. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13188 · Cited by 39
Minhas, G. S., & Newstead, S. L. (2020) · Biochemical Society Transactions · doi:10.1042/bst20180302 · Cited by 41
Recent Advances in Structural Biology of Peptide Transporters
Terada, T., & Inui, K. (2012) · Current topics in membranes · doi:10.1016/b978-0-12-394316-3.00008-9 · Cited by 38
Self-citationAzzolini, M., Mattarei, A., Spina, M. L., Fanin, M., Chiodarelli, G., Romio, M., Zoratti, M., Paradisi, C., & Biasutto, L. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.02.017 · Cited by 39
Protein Digestion and Absorption
Ganapathy, V., Gupta, N., & Martindale, R. G. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50068-4 · Cited by 57
Jappar, D., Hu, Y., Keep, R. F., & Smith, D. E. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9726-9 · Cited by 40
Ma, K., Hu, Y., & Smith, D. E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0580-9 · Cited by 34
“suggest a facilitative transporter is operative at the basolateral membrane (31).”
BackgroundEffect of Milk on the Pharmacokinetics of Oseltamivir in Healthy Volunteers
Morimoto, K., Kishimura, K., Nagami, T., Kodama, N., Ogama, Y., Yokoyama, M., Toda, S., Chiyoda, T., Shimada, R., Inano, A., et al. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22627 · Cited by 35
Tsuji, A. (2006) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0478-3 · Cited by 36
Ding, L., Wang, L., Yu, Z., Ma, S., Du, Z., Zhang, T., & Liu, J. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b03450 · Cited by 34
Computational modelling of H+‐coupled peptide transport via human PEPT1
Irie, M., Terada, T., Katsura, T., Matsuoka, S., & Inui, K. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.084582 · Cited by 34
“In addition, because of its broad substrate specificity, PEPT1 can accept various pharmacologically active compounds, including β-lactam antibiotics, and serve as an absorptive pathway for these drugs (Inui & Terada, 1999; Daniel & Kottra, 2004; Terada & Inui, 2004).”
BackgroundSelf-citationWada, M., Miyakawa, S., Shimada, A., Okada, N., Yamamoto, A., & Fujita, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.064 · Cited by 34
Hauser, M., Kauffman, S., Naider, F. R., Hauser, M., Kauffman, S., Naider, F. R., & Becker, J. M. (2005) · Molecular Membrane Biology · doi:10.1080/09687860500093248 · Cited by 30
“For example, in hPEPT1 the conserved histidine residue H57 in TM 2, has been examined (Daniel & Kottra 2004, Herrera-Ruiz & Knipp 2003, Terada & Inui 2004) indicating that H57, located at the extracellular interface of TM2, is essential for transporter function and plays a role in proton-coupling…”
BackgroundSubstrates of the human oligopeptide transporter hPEPT2
Zhao, D., & Lü, K. (2015) · BioScience Trends · doi:10.5582/bst.2015.01078 · Cited by 28
“Therefore, PEPT2 influences the uptake, efflux, and pharmacological effects of chemical substances, such as peptides and drugs (12).”
BackgroundXing, J., Zhang, S., Zhang, M., & Lin, S. (2017) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.8273 · Cited by 28
Takusagawa, S., Ushigome, F., Nemoto, H., Takahashi, Y., Li, Q., Kerbusch, V., Miyashita, A., Iwatsubo, T., & Usui, T. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300582s · Cited by 27
Liu, Z., Wang, S., & Hu, M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53242-8.00011-4 · Cited by 31
Biological Membranes and Barriers
Omidi, Y., & Gumbleton, M. (2015) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120052223 · Cited by 27
Affinity prediction for substrates of the peptide transporter PepT1
Bailey, P. D., Boyd, C. A. R., Collier, I. D., George, J. P., Kellett, G. L., Meredith, D., Morgan, K. M., Pettecrew, R., & Price, R. A. (2005) · Chemical Communications · doi:10.1039/b511996k · Cited by 26
Mutagenesis and Cysteine Scanning of Transmembrane Domain 10 of the Human Dipeptide Transporter
Xu, L., Haworth, I. S., Kulkarni, A. A., Bolger, M. B., & Davies, D. L. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9952-9 · Cited by 25
Pieri, M., Gan, C., Bailey, P. D., & Meredith, D. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.04.014 · Cited by 25
Synthesis and Evaluation of a Dipeptide–Drug Conjugate Library As Substrates for PEPT1
Zhang, L., Zhang, L., Luo, T., Zhou, J., Sun, L., & Xu, Y. (2012) · ACS Combinatorial Science · doi:10.1021/co200141b · Cited by 23
Pharmacogenomics of MDR and MRP subfamilies
Okamura, N., Sakaeda, T., & Okumura, K. (2004) · Personalized Medicine · doi:10.1517/17410541.1.1.85 · Cited by 25
Wang, C., Chu, C., Ji, X., Luo, G., Xu, C., He, H., Yao, J., Wu, J., Hu, J., & Jin, Y. (2022) · Cells · doi:10.3390/cells11182874 · Cited by 22
Guo, X., Meng, Q., Liu, Q., Wang, C., Sun, H., Kaku, T., & Liu, K. (2012) · Peptides · doi:10.1016/j.peptides.2012.02.009 · Cited by 21
Circadian clock genes and implications for intestinal nutrient uptake
Balakrishnan, A., Tavakkolizadeh, A., & Rhoads, D. B. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.01.002 · Cited by 26
“PEPT1 is a H+-peptide cotransporter that relies on a proton gradient for the uphill transport of peptides, which are subsequently transported across the basolateral membrane by the facilitative basolateral peptide transporter[82].”
Pang, K. S., Peng, H., & Noh, K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040312 · Cited by 22
Foley, D., Pieri, M., Pettecrew, R., Price, R. A., Miles, S., Lam, H. K., Bailey, P. D., & Meredith, D. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b909221h · Cited by 21
Foster, D. R., Landowski, C. P., Zheng, X., Amidon, G. L., & Welage, L. S. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.11.001 · Cited by 20
Liu, Z., & Liu, K. (2013) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2013.07.020 · Cited by 25
“Homologous cDNAs were then found in human, rat, mouse, cow and chicken [35].”
BackgroundEnantioselective Drug Recognition by Drug Transporters
Uwai, Y. (2018) · Molecules · doi:10.3390/molecules23123062 · Cited by 20
“PEPT1 recognizes peptide-like β-lactam antibiotics that are orally administered [8].”
BackgroundXu, J., Zeug, A., Riederer, B., Yeruva, S., Griesbeck, O., Daniel, H., Tuo, B., Ponimaskin, E. G., Dong, H. F., & Seidler, U. E. (2020) · Physiological Reports · doi:10.14814/phy2.14337 · Cited by 18
“…majority are further hydrolyzed and exported as aminoacids, but a fraction is also exported as dipeptides by as yet molecularly undefined carriers (Terada & Inui, 2004), In order to get more insight into the mechanisms we carried out studies in Slc15a1−/−-CAGTN-XXL mouse, the percentage of…”
BackgroundGuo, X., Meng, Q., Liu, Q., Wang, C., Mao, Q., Sun, H., Peng, J., Kaku, T., & Liu, K. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-089 · Cited by 17
Targeting ketone drugs towards transport by the intestinal peptide transporter, PepT1
Foley, D., Bailey, P. D., Pieri, M., & Meredith, D. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b818606e · Cited by 17
Metadata
- Authors
- Terada, T., & Inui, K.-I.
- Affiliations
- Kyoto University (JP)
- Kyoto University Hospital (JP)
- Corresponding author
- Inui, Ken-ichi
- Venue
- Current Drug Metabolism
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2004-02-01
- Volume
- 5
- Issue
- 1
- Pages
- 85-94
- ISSN
- 1389-2002 (ISSN-L)
- OpenAlex
- W138900185
- Cited by
- 177
- References
- 0
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 2 · 2022: 6 · 2021: 2 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 9 · 2016: 4 · 2015: 4 · 2014: 4 · 2013: 7 · 2012: 12
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- peptide transporters, PepT1, PEPT2, drug delivery, valacyclovir, intestinal epithelium, renal epithelium, brush border membrane, basolateral membrane, beta-lactam antibiotics, structure-function relationship, transporter regulation, amino acid uptake
- MeSH terms
- Peptide Transporter 1, Animals, Biological Transport, Carrier Proteins, Pharmaceutical Preparations, Humans, Organ Specificity, Peptides, Pharmacokinetics, Protein Conformation, Symporters
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.